Virtual-Integrated Twin for Autonomous Lifesaving (VITAL)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative approaches for its Virtual-Integrated Twin for Autonomous Lifesaving (VITAL) program. This initiative aims to develop continuously updating digital twin models of the cardiovascular system to simulate interventions and predict outcomes in real-time, shifting medical care from reactive to anticipatory. An amendment clarifies the abstract questions deadline and submission requirements.
Purpose & Scope
The VITAL program seeks to establish a foundation for causal, prediction-driven decision support in medicine. This involves developing both High Fidelity (HF) digital twin models and Reduced Order Models (ROMs) that combine patient data with biological physics. These models will be integrated into a pipeline to simulate interventions and predict their outcomes before actual application, improving outcomes across acute, chronic, and emergent clinical settings. Focus areas include chronic conditions (e.g., heart failure) or acute perturbations (e.g., hemorrhagic shock).
Contract Details
DARPA anticipates making multiple awards under Other Transaction for Prototype agreements. The anticipated period of performance is 36 months, divided into two phases (Phase 1: 15 months, Phase 2: 21 months).
Eligibility & Set-Aside
This opportunity is open to all responsible sources, including large and small businesses, non-traditional defense contractors, universities, and research institutions. There is no specific set-aside designated.
Submission & Key Dates
Proposers must first submit an abstract to be considered for an invitation to submit an Oral Presentation Proposal (OPP) package.
- Abstract Questions Due: May 13, 2026, 12:00 PM ET (send to VITAL@darpa.mil).
- Abstract Submission Deadline: May 20, 2026, 5:00 PM ET.
- Abstract Requirements: Max 7 pages for main content (Technical Approach, Challenges, Ability), following
Attachment_A_Abstract_Template_And_Instructions_VITAL_V2.docx. The title page, estimated cost, and references are excluded from this limit. AnAttachment_B_Abstract_Summary_Slide_Template.pptxis also required. - Anticipated Oral Presentation Package Submission Due: July 10, 2026.
- Anticipated Oral Presentation Date: July 23, 2026.
Evaluation Criteria
Abstracts will be evaluated based on Technical Approach, Technical Ability, and Budget. For invited Oral Presentation Proposals, evaluation criteria (in descending order of importance) are Technical Approach, Relevant Qualifications, Budget, and Data Rights.
Contact Information
For questions, contact Dr. Roozbeh Jafari, Program Manager, DARPA/BTO at VITAL@darpa.mil.